Page last updated: 2024-08-21

indazoles and Malignant Neurilemmoma

indazoles has been researched along with Malignant Neurilemmoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ae, K; Ando, M; Ando, Y; Goto, T; Hamada, S; Hiraga, H; Kawai, A; Kobayashi, E; Kuwatsuka, Y; Matsumoto, Y; Naka, N; Nakayama, R; Nishida, Y; Ozaki, T; Takahashi, S; Tsuchiya, H; Ueda, T; Urakawa, H	1

Trials

1 trial(s) available for indazoles and Malignant Neurilemmoma

Article	Year
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors. International journal of cancer, 2021, 01-01, Volume: 148, Issue:1 Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Neoplasm Grading; Neurofibrosarcoma; Neutropenia; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Severity of Illness Index; Sulfonamides; Young Adult	2021

Article

Year

Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.

International journal of cancer, 2021, 01-01, Volume: 148, Issue:1

Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Neoplasm Grading; Neurofibrosarcoma; Neutropenia; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Severity of Illness Index; Sulfonamides; Young Adult

2021